These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 33838155

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L, Zhang Y.
    Biochem Biophys Res Commun; 2015 Feb 13; 457(3):370-7. PubMed ID: 25580008
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW, Lu ZY, Pan Q, Chen TT, Feng XJ, Wang SM, Pan YC, Zhu MH, Zhang SH.
    Phytomedicine; 2019 Apr 13; 57():18-29. PubMed ID: 30668319
    [Abstract] [Full Text] [Related]

  • 4. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
    Tang H, Zhang J, Yu Z, Ye L, Li K, Ding F, Feng X, Meng W.
    Technol Cancer Res Treat; 2017 Dec 13; 16(6):1136-1149. PubMed ID: 29332449
    [Abstract] [Full Text] [Related]

  • 5. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
    Qi Y, Yao X, Du X.
    IUBMB Life; 2020 Mar 13; 72(3):452-464. PubMed ID: 31651086
    [Abstract] [Full Text] [Related]

  • 6. MiR-128-3p overexpression sensitizes hepatocellular carcinoma cells to sorafenib induced apoptosis through regulating DJ-1.
    Guo XL, Wang HB, Yong JK, Zhong J, Li QH.
    Eur Rev Med Pharmacol Sci; 2018 Oct 13; 22(20):6667-6677. PubMed ID: 30402839
    [Abstract] [Full Text] [Related]

  • 7. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D, Xing N, Yang T, Liu J, Zhao H, He J, Ai Y, Yang J.
    Cancer Med; 2020 Oct 13; 9(19):7218-7230. PubMed ID: 32767662
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 13; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.
    Cheng J, Wu LM, Deng XS, Wu J, Lv Z, Zhao HF, Yang Z, Ni Y.
    Hepatobiliary Pancreat Dis Int; 2018 Aug 13; 17(4):336-344. PubMed ID: 30108016
    [Abstract] [Full Text] [Related]

  • 13. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 14. Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.
    Liao YJ, Bai HY, Li ZH, Zou J, Chen JW, Zheng F, Zhang JX, Mai SJ, Zeng MS, Sun HD, Pu JX, Xie D.
    Cell Death Dis; 2014 Mar 20; 5(3):e1137. PubMed ID: 24651440
    [Abstract] [Full Text] [Related]

  • 15. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
    Zhao L, Wang Y, Liu Q.
    Exp Mol Pathol; 2019 Aug 20; 109():51-60. PubMed ID: 31145886
    [Abstract] [Full Text] [Related]

  • 16. Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling.
    Yu X, Tang W, Yang Y, Tang L, Dai R, Pu B, Feng C, Xia J.
    Chem Biol Interact; 2018 Apr 01; 285():48-58. PubMed ID: 29481769
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MicroRNA-26b suppresses the NF-κB signaling and enhances the chemosensitivity of hepatocellular carcinoma cells by targeting TAK1 and TAB3.
    Zhao N, Wang R, Zhou L, Zhu Y, Gong J, Zhuang SM.
    Mol Cancer; 2014 Feb 24; 13():35. PubMed ID: 24565101
    [Abstract] [Full Text] [Related]

  • 20. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y, Du J, Liu Z, Zhang D, Yao X, Yang Y.
    J Exp Clin Cancer Res; 2019 Jan 08; 38(1):7. PubMed ID: 30621734
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.